Darkside of Medicine
Teratogenic Medication
Teratogenic medicines are drugs that can cause harm to a developing baby during pregnancy. These medicines have the potential to interfere with normal growth and development before birth, and their use requires clear communication, strong safeguards, and informed decision‑making.
While many medicines are safe during pregnancy, many are medically necessary; those known to carry teratogenic risks must only be prescribed when no safer alternative exists and when patients are fully informed.
How Teratogenic Medicines Can Affect Pregnancy
Key Risks
Exposure to teratogenic medicines during pregnancy can increase the likelihood of:
-
Birth defects (e.g., heart abnormalities, cleft palate, limb differences)
-
Growth restrictions (babies smaller than expected)
-
Neurodevelopmental conditions (learning difficulties, autism, ADHD)
-
Pregnancy complications, including miscarriage or stillbirth
The understanding of the effects of teratogens is still growing; it is important to talk to your doctor about your medication if you are planning to become pregnant.
For a comprehensive list of teratogenic medicines, visit the website of UKTIS https://uktis.org
Why Awareness Matters
Advocacy Spotlight
Too many women and families are still not given clear, accessible information about the risks of teratogenic medicines.
Raising awareness ensures that:
-
Women and families can make fully informed decisions
-
Healthcare professionals consider safer alternatives
-
Society recognises the long‑term impact of avoidable harm
Awareness is not only a clinical issue, but it is also a matter of patient rights, transparency, and justice.
Protecting Future Generations
Preventing avoidable harm requires:
-
Stronger safety measures and prescribing safeguards
-
Better education for healthcare professionals
-
Full transparency for patients
-
Support for families already affected
By sharing accurate information and advocating for safer practices, we can help protect future generations and ensure that no family faces preventable harm.
📢 Call to Action: Stand With Us to Prevent Avoidable Harm
Every family deserves clear information, safe treatment, and protection from preventable risks.
Your voice can help drive change.
-
Mandatory, consistent communication of teratogenic risks
-
Stronger pregnancy‑prevention programmes
-
Improved training for healthcare professionals
-
National support services for affected families
-
Greater accountability and transparency across the healthcare system
The Formulary
In the UK, we use the British National Formulary, which is part of the NICE (National Institute for Health and Care Excellence). The BNF provides Key information on the selection, prescribing, dispensing and administration of medicines. The BNF is a resource that provides information about medicines. It includes details such as indications, dosage, contraindications, cautions, interactions, and side effects and information for use during pregnancy and breastfeeding
Your Local Formulary
The Department for Health ensures that patients and service users have access to recommended medicines and medical devices. A formulary is a locally developed list of medicines deemed suitable for prescribing by the local NHS. The formulary must be published online so that patients and service users can understand the treatments available on the NHS,
It may also include some other products which can be provided on prescription, such as dressings. The formulary covers:
-
prescriptions written in primary care
-
prescriptions or recommendations by hospital doctors of outpatients or patients leaving the hospital after an admission
In these situations, prescribers are asked to take the medicine e list fully into account when deciding how to treat patients.
Under the NHS framework, Integrated Care Boards now oversee medicines governance and formulary decisions, guided by NICE assessments and local evidence. They collaborate with prescribing committees to evaluate clinical and cost-effectiveness, develop formularies, and implement guidance. Medicines not positively appraised by NICE are decided locally, with transparency and rationality, ensuring patient rights and proper governance across primary and secondary care.